These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 24512823)

  • 1. Ornithine phenylacetate targets alterations in the expression and activity of glutamine synthase and glutaminase to reduce ammonia levels in bile duct ligated rats.
    Jover-Cobos M; Noiret L; Lee K; Sharma V; Habtesion A; Romero-Gomez M; Davies N; Jalan R
    J Hepatol; 2014 Mar; 60(3):545-53. PubMed ID: 24512823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interorgan metabolism of ornithine phenylacetate (OP)--a novel strategy for treatment of hyperammonemia.
    Dadsetan S; Sørensen M; Bak LK; Vilstrup H; Ott P; Schousboe A; Jalan R; Keiding S; Waagepetersen HS
    Biochem Pharmacol; 2013 Jan; 85(1):115-23. PubMed ID: 23103564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ammonia reduction with ornithine phenylacetate restores brain eNOS activity via the DDAH-ADMA pathway in bile duct-ligated cirrhotic rats.
    Balasubramaniyan V; Wright G; Sharma V; Davies NA; Sharifi Y; Habtesion A; Mookerjee RP; Jalan R
    Am J Physiol Gastrointest Liver Physiol; 2012 Jan; 302(1):G145-52. PubMed ID: 21903766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-ornithine and phenylacetate synergistically produce sustained reduction in ammonia and brain water in cirrhotic rats.
    Davies NA; Wright G; Ytrebø LM; Stadlbauer V; Fuskevåg OM; Zwingmann C; Davies DC; Habtesion A; Hodges SJ; Jalan R
    Hepatology; 2009 Jul; 50(1):155-64. PubMed ID: 19437490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ornithine phenylacetate revisited.
    Jover-Cobos M; Noiret L; Sharifi Y; Jalan R
    Metab Brain Dis; 2013 Jun; 28(2):327-31. PubMed ID: 23456516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current state of knowledge of hepatic encephalopathy (part I): newer treatment strategies for hyperammonemia in liver failure.
    Kristiansen RG
    Metab Brain Dis; 2016 Dec; 31(6):1357-1358. PubMed ID: 27651377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in hyperammonaemia by ornithine phenylacetate prevents lipopolysaccharide-induced brain edema and coma in cirrhotic rats.
    Wright G; Vairappan B; Stadlbauer V; Mookerjee RP; Davies NA; Jalan R
    Liver Int; 2012 Mar; 32(3):410-9. PubMed ID: 22151131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ammonia produces pathological changes in human hepatic stellate cells and is a target for therapy of portal hypertension.
    Jalan R; De Chiara F; Balasubramaniyan V; Andreola F; Khetan V; Malago M; Pinzani M; Mookerjee RP; Rombouts K
    J Hepatol; 2016 Apr; 64(4):823-33. PubMed ID: 26654994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile-duct ligation renders the brain susceptible to hypotension-induced neuronal degeneration: Implications of ammonia.
    Clément MA; Bosoi CR; Oliveira MM; Tremblay M; Bémeur C; Rose CF
    J Neurochem; 2021 May; 157(3):561-573. PubMed ID: 33382098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-ornithine phenylacetate attenuates increased arterial and extracellular brain ammonia and prevents intracranial hypertension in pigs with acute liver failure.
    Ytrebø LM; Kristiansen RG; Maehre H; Fuskevåg OM; Kalstad T; Revhaug A; Cobos MJ; Jalan R; Rose CF
    Hepatology; 2009 Jul; 50(1):165-74. PubMed ID: 19554542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-Ornithine phenylacetate reduces ammonia in pigs with acute liver failure through phenylacetylglycine formation: a novel ammonia-lowering pathway.
    Kristiansen RG; Rose CF; Fuskevåg OM; Mæhre H; Revhaug A; Jalan R; Ytrebø LM
    Am J Physiol Gastrointest Liver Physiol; 2014 Nov; 307(10):G1024-31. PubMed ID: 25258408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ammonia mediates cortical hemichannel dysfunction in rodent models of chronic liver disease.
    Hadjihambi A; De Chiara F; Hosford PS; Habtetion A; Karagiannis A; Davies N; Gourine AV; Jalan R
    Hepatology; 2017 Apr; 65(4):1306-1318. PubMed ID: 28066916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal brain oxygen homeostasis in an animal model of liver disease.
    Hadjihambi A; Cudalbu C; Pierzchala K; Simicic D; Donnelly C; Konstantinou C; Davies N; Habtesion A; Gourine AV; Jalan R; Hosford PS
    JHEP Rep; 2022 Aug; 4(8):100509. PubMed ID: 35865351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene Therapy for Treatment of Chronic Hyperammonemia in a Rat Model of Hepatic Encephalopathy.
    Espíritu-Ramírez P; Ortega-Balderas NY; Sevilla-Tapia L; Montiel-Martínez AG; Pastor-Flores AR; Palomares LA; Torres-Vega MA
    Ann Hepatol; 2018 Oct; 17(6):1026-1034. PubMed ID: 30600292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive resistance training prevents loss of muscle mass and strength in bile duct-ligated rats.
    Aamann L; Ochoa-Sanchez R; Oliveira M; Tremblay M; Bémeur C; Dam G; Vilstrup H; Aagaard NK; Rose CF
    Liver Int; 2019 Apr; 39(4):676-683. PubMed ID: 30394651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ornithine phenylacetate prevents disturbances of motor-evoked potentials induced by intestinal blood in rats with portacaval anastomosis.
    Oria M; Romero-Giménez J; Arranz JA; Riudor E; Raguer N; Córdoba J
    J Hepatol; 2012 Jan; 56(1):109-14. PubMed ID: 21835138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-Ornithine phenylacetate (OP): a novel treatment for hyperammonemia and hepatic encephalopathy.
    Jalan R; Wright G; Davies NA; Hodges SJ
    Med Hypotheses; 2007; 69(5):1064-9. PubMed ID: 17467190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of glutamine synthetase inhibition on brain and interorgan ammonia metabolism in bile duct ligated rats.
    Fries AW; Dadsetan S; Keiding S; Bak LK; Schousboe A; Waagepetersen HS; Simonsen M; Ott P; Vilstrup H; Sørensen M
    J Cereb Blood Flow Metab; 2014 Mar; 34(3):460-6. PubMed ID: 24346692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically engineered E. coli Nissle attenuates hyperammonemia and prevents memory impairment in bile-duct ligated rats.
    Ochoa-Sanchez R; Oliveira MM; Tremblay M; Petrazzo G; Pant A; Bosoi CR; Perreault M; Querbes W; Kurtz CB; Rose CF
    Liver Int; 2021 May; 41(5):1020-1032. PubMed ID: 33548108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic oxidative stress is implicated in the pathogenesis of brain edema in rats with chronic liver failure.
    Bosoi CR; Yang X; Huynh J; Parent-Robitaille C; Jiang W; Tremblay M; Rose CF
    Free Radic Biol Med; 2012 Apr; 52(7):1228-35. PubMed ID: 22300646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.